Evidence map›Paper›PMID 31024905›Full record

ArticleFrontiers in bioengineering and biotechnology2019

Imaging of Red-Shifted Light From Bioluminescent Tumors Using Fluorescence by Unbound Excitation From Luminescence.

Fabiane Sônego, Sophie Bouccara, Thomas Pons, Nicolas Lequeux, Anne Danckaert, Jean-Yves Tinevez, Israt S Alam, Spencer L Shorte, Régis Tournebize

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Monitoring RVFV Infection Using Bioluminescent Reporter Viruses In Vivo.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  2. Article
  3. Near-Infrared Inorganic Nanomaterials for Precise Diagnosis and Therapy.Frontiers in bioengineering and biotechnology · 2021
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Fabiane SônegoUTechS Photonic BioImaging, C2RT, Institut Pasteur, Paris, France.
Sophie BouccaraUTechS Photonic BioImaging, C2RT, Institut Pasteur, Paris, France.
Thomas PonsLaboratoire de Physique et d'Etude des Matériaux, ESPCI Paris, CNRS UMR8213, PSL Research University, Université Pierre et Marie Curie, Sorbonne-Universités, Paris, France.
Nicolas LequeuxLaboratoire de Physique et d'Etude des Matériaux, ESPCI Paris, CNRS UMR8213, PSL Research University, Université Pierre et Marie Curie, Sorbonne-Universités, Paris, France.
Anne DanckaertUTechS Photonic BioImaging, C2RT, Institut Pasteur, Paris, France.
Jean-Yves TinevezUTechS Photonic BioImaging, C2RT, Institut Pasteur, Paris, France.
Israt S AlamUTechS Photonic BioImaging, C2RT, Institut Pasteur, Paris, France.
Spencer L ShorteUTechS Photonic BioImaging, C2RT, Institut Pasteur, Paris, France.
Régis TournebizeUTechS Photonic BioImaging, C2RT, Unité Pathogénie Microbienne Moléculaire, Institut Pasteur, INSERM U1202, Paris, France.
Institut Pasteur · FRCentre National de la Recherche Scientifique · FRESPCI Paris · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early detection of tumors is today a major challenge and requires sensitive imaging methodologies coupled with new efficient probes.

Indexed as

bioluminescencefluorescencein vivo optical imagingquantum dot (QD)tumor

Identifiers

PMID31024905
PMCPMC6460942
OpenAlexW2949874113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.